Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03896334
Other study ID # ISOPRESS_MULTICENTER STUDY
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 5, 2019
Est. completion date December 15, 2024

Study information

Verified date May 2024
Source Universidade Federal de Santa Catarina
Contact Aline Gerage, PhD
Phone 554837218554
Email alinegerage@yahoo.com.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Meta-analysis studies have demonstrated that isometric training with handgrip promotes reductions in clinical blood pressure, reaching 8 mmHg for systolic blood pressure and 4 mmHg for diastolic. However, the effects of this training modality on ambulatory blood pressure, which is better discriminant of cardiovascular risk than clinical BP, remains uncertain. Thus, the ISOPRESS Network, consists of researchers from Brazilian institutions of education and research (Federal University of Santa Catarina, Federal University of Amazonas, Federal University of Sergipe, Federal Rural University of Pernambuco and Universidade Nove de Julho), will conduct a multi-center study to analyze the effects of isometric handgrip training on clinic and 24-h ambulatory blood pressure in patients with hypertension. For this, each research center will conduct a randomized controlled trial with medicated patients with hypertension, of both sex. The participants will be randomized into two groups: isometric handgrip training group (HBT: n = 25 per center) and control group (CG: n = 25 per center).Subjects assigned to the HBT will train three times per week, four sets of 2-min isometric contractions (using alternate hands) at 30% of maximal voluntary contraction, during 24 weeks. Subjects randomized to the CG will perform stretching and relaxation exercises three times per week, during 24 weeks. The evaluations will occur in three moments: baseline, post-12 and post-24 weeks. The primary outcome will be ambulatory blood pressure, while clinic blood pressure and cardiac autonomic modulation will be analyzed as secondary outcomes. For data analysis, in addition to descriptive statistics, two-way ANOVA for mixed model will be applied for within and between groups comparison. The level of significance that will be adopted is p<0.05.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date December 15, 2024
Est. primary completion date July 15, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of hypertension, controlled by up to three antihypertensive medications - Blood pressure levels between 130 and 180 mmHg - No high cardiovascular risk (no other cardiovascular, metabolic or pulmonary disease nor any signals or symptoms of these disease) - Not engaged in a physical exercise program for at least six months - Not present cognitive impairment (Montreal Cognitive Assessment = 26 points) Exclusion Criteria: - Adherence to less than 85% of training sessions - Diagnosis of other cardiovascular diseases or diabetes during the course of the study - Adherence to another supervised physical exercise program - Change in medication class and/ or dose during the study - Aggravation of the disease (i.e. blood pressure above 180 or use of four or more medications).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Supervised Isometric Handgrip Training
The participants randomized to the experimental group will perform 24 weeks of isometric handgrip exercise training, three times/week for 16 minutes with time to rest.
Sham comparator - stretching and relaxation exercises
The participants randomized to the control group (active comparator) will perform 24 weeks of stretching and relaxation exercise training, three times/week for 16 minutes with time to rest.

Locations

Country Name City State
Brazil Federal University of Sergipe Aracaju
Brazil Universidade Federal de Santa Catarina Florianopolis Santa Catarina
Brazil Federal University of Amazonas Parintins
Brazil Federal Rural University of Pernambuco Recife
Brazil Universidade Nove de Julho São Paulo

Sponsors (2)

Lead Sponsor Collaborator
Universidade Federal de Santa Catarina Conselho Nacional de Desenvolvimento Científico e Tecnológico

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in ambulatory systolic blood pressure 24h-ambulatory blood pressure monitoring Baseline, 12 weeks 24 weeks
Primary Change in ambulatory diastolic blood pressure 24h-ambulatory blood pressure monitoring Baseline, 12 weeks 24 weeks
Primary Change in ambulatory mean blood pressure 24h-ambulatory blood pressure monitoring Baseline, 12 weeks 24 weeks
Secondary Change in clinic systolic blood pressure Clinic blood pressure will be checked using an automatic instrument Baseline, 12 weeks 24 weeks
Secondary Change in clinic diastolic blood pressure Clinic blood pressure will be checked using an automatic instrument Baseline, 12 weeks 24 weeks
Secondary Change in clinic mean blood pressure Clinic blood pressure will be checked using an automatic instrument Baseline, 12 weeks 24 weeks
Secondary Change in heart rate variability For heart rate variability assessment, R-R interval will be obtained using a heart rate monitor (POLAR, RS 800CX), following the recommendations of the Task Force of the European Society of Cardiology and the North American. Baseline, 12 weeks 24 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A